1. The safety and tolerability of sumatriptan: an overview;Brown, E.G.; Endersby, C.A.; Smith, R.N.; Talbot, J.C.C.;EurNeurol,1991
2. Coronary vasospasm and sumatriptan;Stricker, B.H.C.;BMJ,1992
3. Coronary vasospasm induced by subcutaneous sumatriptan;Willet, F.; Curzen, N.; Adams, J.; Armitage, M.;BMJ,1992
4. Stricker BHCh. Transmural myocardial infarction with sumatriptan;Ottervanger, J.P.; Paalman, H.J.A.; Boxma, G.L.;Lancet,1993
5. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation;Maclntyre, P.D.; Bhargava, B.; Hogg, K.J.; Gemmill, J.D.; Hillis, W.S.;Circulation,1993